Service implications of the revised 2022 National Institute for Health and Care Excellence (NICE) follow-up guidelines for stage IA-IIC melanoma.
Thomas D DobbsMathew JovicNattawan EkakkaravichitStephen R AliJohn Alexander Gerald GibsonNader IbrahimSarah Hemington-GorseIain S WhitakerPublished in: The British journal of surgery (2024)
Melanoma follow-up guideline changes will result in a substantial reduction in the number of clinical follow-up appointments, but a significant additional burden to radiological services. The overall cost of follow-up at a national level will be reduced.